This is a revised (A2) continuation application to extend an Institutional Postdoctoral Training Program in Drug Abuse Treatment and Services Research. Areas of focus are: (1) clinical trials of behavioral, psychosocial and pharmacological interventions, including the """"""""Stage I"""""""" developmental work that leads to clinical trials;(2) studies of processes that contribute to outcome;(3) efficacy and effectiveness of interventions in practice settings;and (4) intervention dissemination and diffusion. Trainees will be admitted for two years with the possibility of a third year. The exceptional trainee will be admitted for a one-year training program. In the past 15 years, the program has successfully trained 43 doctoral level nurses, psychologists, social workers, and public health and policy scientists for academic and research careers. Recent changes in policy and public perception of drug abuse serve to increase the already pressing need for outstanding researchers in treatment and services research. The program exists in an environment rich with relevant resources, including links with multiple, diverse clinical sites, and a variety of academic centers and activities that supplement and enrich the training experience. A seven-member Executive Committee, Drs. Hall, Sorensen, Batki,, Delucchi, Guydish, Masson, and Weisner, directs the program. Core Faculty include biostatisticians, internists, psychiatrists, and psychologists. We will have a total of 6 trainees each year, in their first or second year of placement, or possibly their third year. All trainees participate in the Drug Abuse Research Seminar and Transmethodological Lecture Series and a course on the Responsible Conduct of Science, and one other course each semester selected from the wide array offered. Trainees'research projects are closely tied to those of their preceptors. As trainees move from year 1 to year 2, they progress from a project designed by their preceptor to an independently conceived project, which the trainee leads. Trainees are expected to make multiple scientific presentations, submit articles for publication, and prepare as well as revise grant submissions while in the program.

Public Health Relevance

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Institutional National Research Service Award (T32)
Project #
3T32DA007250-16A2S1
Application #
8082150
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Subramaniam, Geetha A
Project Start
1991-09-30
Project End
2014-06-30
Budget Start
2010-06-07
Budget End
2010-06-30
Support Year
16
Fiscal Year
2010
Total Cost
$24,039
Indirect Cost
Name
University of California San Francisco
Department
Psychiatry
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Pagano, Anna; Gubner, Noah R; Le, Thao et al. (2018) Differences in tobacco use prevalence, behaviors, and cessation services by race/ethnicity: A survey of persons in addiction treatment. J Subst Abuse Treat 94:9-17
Ramo, Danielle E; Bahorik, Amber L; Delucchi, Kevin L et al. (2018) Alcohol and Drug Use, Pain and Psychiatric Symptoms among Adults Seeking Outpatient Psychiatric Treatment: Latent Class Patterns and Relationship to Health Status. J Psychoactive Drugs 50:43-53
Horyniak, Danielle; Strathdee, Steffanie A; West, Brooke S et al. (2018) Predictors of injecting cessation among a cohort of people who inject drugs in Tijuana, Mexico. Drug Alcohol Depend 185:298-304
Bahorik, Amber L; Sterling, Stacy A; Campbell, Cynthia I et al. (2018) Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization. J Affect Disord 241:8-14
Vogel, Erin A; Rubinstein, Mark L; Prochaska, Judith J et al. (2018) Associations between marijuana use and tobacco cessation outcomes in young adults. J Subst Abuse Treat 94:69-73
Cooke, Alexis C; Knight, Kelly R; Miaskowski, Christine (2018) Patients' and clinicians' perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care. Int J Drug Policy 63:23-28
Kim-Mozeleski, Jin E; Tsoh, Janice Y; Ramirez-Forcier, Joseph et al. (2018) Smoking Predicts Food Insecurity Severity among Persons Living with HIV. AIDS Behav 22:2861-2867
Meacham, Meredith C; Roesch, Scott C; Strathdee, Steffanie A et al. (2018) Perceived Treatment Need and Latent Transitions in Heroin and Methamphetamine Polydrug Use among People who Inject Drugs in Tijuana, Mexico. J Psychoactive Drugs 50:62-71
Bahorik, Amber L; Campbell, Cynthia I; Sterling, Stacy A et al. (2018) Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder. Psychiatry Res 259:316-322
Gubner, Noah R; Williams, Denise D; Pagano, Anna et al. (2018) Menthol cigarette smoking among individuals in treatment for substance use disorders. Addict Behav 80:135-141

Showing the most recent 10 out of 165 publications